In animal studies, the IC 50 value of alogliptin for DPP4 was 7 nmol/L, whereas for DPP2, DPP8, and DPP9, the IC50 values were greater than 100 000 nmol/L, showing a more than 10 000fold preference for DPP4 over these other enzymes [96]
Testing Methodology We tested the Zeee battery using three main methods: a 105A load test, a C rating test, and an internal resistance test
doi:10.1023/b:mebr.0000043979.58915.41[PubMed] 82
Weight Loss Clinical Trial Results In Phase 2 clinical trials: Participants receiving 12 mg experienced up to 24.2% average body weight loss at 48 weeks Additional studies reported up to 28.7% weight reduction at 68 weeks Higher doses (8 mg and 12 mg) demonstrated the most significant results These findings suggest Retatrutide may outperform current GLP-1 therapies and dual-agonist medications in terms of total weight loss
The MHRA has confirmed that retatrutide does not hold a UK marketing authorisation, and the risks of using unlicensed injectable compounds obtained outside approved trials are serious and cannot be fully mitigated by careful preparation alone